CClinicalTrials.gg
Status unknownNCT03766230Updated Dec 6, 2018

Clinical Study on Second-eye Pain in Cataract Surgery

An observational study in Senile Cataract, sponsored by Shanghai Eye Disease Prevention and Treatment Center. Status unknown. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2018-12-06.

Sponsored by Shanghai Eye Disease Prevention and Treatment Center · Observational

The sponsor has not verified this record recently (last verified Nov 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
600
Ages
40 Years to 80 Years
Sex
All
01

Study summary

The degree of perceived pain in the second-eye surgery of cataract patients is significantly higher than that in the first-eye surgery, which can lead to nervous tension during surgery and affect the surgical outcome and satisfaction. Study suggested that in addition to psychological factors, there might be subclinical sympathetic reactions leading to increased pain in the second-eyes, but the objective indicators and clinical relevance are not clear. Therefore, it is necessary to study the mechanism of second-eye pain in cataract surgery, and to provide a test index that can effectively predict the degree of intraoperative pain in patients, as an important reference for the development of a suitable time for second eye surgery.

This study is based on clinical case studies, recruiting patients with clinically diagnosed binocular age-related cataract and require binocular surgery, to compare the correlation of intraocular inflammatory factors in the second eye and patients' self-pain scores while both eyes' surgery are completed by the same doctor in the same operating room, and the correlation of the change of inflammatory factors and the time interval between the two eyes surgery, to analyze the second-eye subclinical sympathetic reaction changing with the time interval after the first cataract surgery from the molecular biological results. Using the latest international anterior segment vascularization optical coherence tomography(OCT) scan and optical microvascular imaging(OMAG) analysis technology to quantify iris blood flow, this study analyzes the iris blood flow density, vascular density and other indicators before and after cataract surgery, and carry out its correlation with the degree of intraocular subclinical sympathetic reaction, providing a rapid, non-invasive objective examination index of the second-eye subclinical sympathetic response.

Read the detailed description
  1. Coordination and Quality Control Team: The inspection and audit of this research project will be established mainly by hospital clinical research center staff and assisted by the Ophthalmology Reading Center team;
  2. The project team member will accept training before the study begins while unified inspection methods and requirements is established in standard operating procedures.
  3. The project team double enter the test data independently and establishes an electronic database.
  4. The project team randomly selects the data and repeats the measurements to ensure the accuracy as internal audit regularly.
02

Conditions studied

  • Senile Cataract

Browse trials for

03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's planned enrollment of 600 is above the median of 81 across 484 observational studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Shanghai Eye Disease Prevention and Treatment Center is the lead sponsor of 64 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Binocular senile cataract patients with binocular phacoemulsification and intraocular lens implantation to be performed at the Department of Ophthalmology in Shanghai Eye Disease Prevention and Treatment Center or Shanghai General Hospital from August 2018 to August 2020.

Inclusion criteria

  1. diagnosed with binocular age-related cataract.
  2. Both eyes require phacoemulsification and intraocular lens implantation.
  3. binocular surgery was performed by the same physician in the same operating room, and the anesthesia and surgical procedures were consistent.
  4. Patients can fully understand the research purpose, research content, accidents and benefits and risks of the clinical trial, and can make their own decisions on participating or not.

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
600 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • peribulbar anesthesia1

    Time interval between two eyes' cataract surgery is or less than 14 days and using peribulbar anesthesia

  • topical anesthesia1

    Time interval between two eyes' cataract surgery is or less than 14 days and using topical anesthesia

  • peribulbar anesthesia2

    Time interval between two eyes' cataract surgery is from 15 to 21 days and using peribulbar anesthesia

  • topical anesthesia2

    Time interval between two eyes' cataract surgery is from 15 to 21 days and using topical anesthesia

  • peribulbar anesthesia3

    Time interval between two eyes' cataract surgery is from 22 to 28 days and using peribulbar anesthesia

  • topical anesthesia3

    Time interval between two eyes' cataract surgery is from 22 to 28 days and using topical anesthesia

  • peribulbar anesthesia4

    Time interval between two eyes' cataract surgery is from 29 to 60 days and using peribulbar anesthesia

  • topical anesthesia4

    Time interval between two eyes' cataract surgery is from 29 to 60 days and using topical anesthesia

  • peribulbar anesthesia5

    Time interval between two eyes' cataract surgery is from 61 to 90 days and using peribulbar anesthesia

  • topical anesthesia5

    Time interval between two eyes' cataract surgery is from 61 to 90 days and using topical anesthesia

06

What researchers measure

Primary outcomes

  1. Change in Surgery Pain Severity Score

    visual analogue scale is used to assess the surgery pain. Visual analogue scales (VAS) are psychometric measuring instruments designed to document the characteristics of disease-related symptom severity in individual patients. A VAS is usually a 100-mm long horizontal line with verbal descriptors (word anchors) at each end to express the extremes of the feeling, the position of the respondent's cross is generally assigned a score between 0 and 100.

    Time frame: Within one hour after first eye surgery; within one hour after second eye surgery (performed up to 90 days after first eye surgery)

Secondary outcomes

  1. Change in Concentration of inflammatory factors in aqueous humor

    the Concentrations of tumor necrosis factor-α,interleukin-1,interleukin-6,interleukin-8,monocyte chemotactic protein-1,interleukin2,macrophage inflammatory protein-1α,macrophage inflammatory protein-1,carbon tetrachloride ,chemokine ligand 9,Tissue inhibitor of matrix metalloproteinase 01,C-C motif chemokine 11 are measured using Luminex

    Time frame: aqueous humor is acquired at the beginning of the first eye surgery and the second eye surgery (performed up to 90 days after first eye surgery)

  2. Change in blood flow density of iris vascular

    CIRRUS High Definition-OCT 5000(Carl Zeiss Meditec, Dublin, CA)

    Time frame: Within 24 hours before first eye surgery and Day 1, Week 1, Week 3, Month 1, Month 3 after first eye surgery, or within 24 hours before second-eye surgery (performed up to 90 days after first eye surgery)

  3. Change in vascular density of iris vascular

    CIRRUS High Definition-OCT 5000(Carl Zeiss Meditec, Dublin, CA)

    Time frame: Within 24 hours before first eye surgery and Day 1, Week 1, Week 3, Month 1, Month 3 after first eye surgery, or within 24 hours before second-eye surgery (performed up to 90 days after first eye surgery)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03766230
Lead sponsor
Shanghai Eye Disease Prevention and Treatment Center
Collaborators
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Responsible party
Sponsor
First posted
Dec 6, 2018
Start date
Dec 30, 2018 (estimated)
Primary completion
Aug 30, 2021 (estimated)
Completion
Oct 30, 2021 (estimated)
Last update
Dec 6, 2018
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion